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Abstract
CRTR-1 is a member of the CP2 family of transcription factors. Unlike other members of the family which are widely
expressed, CRTR-1 expression shows specific spatio-temporal regulation. Gene targeting demonstrates that CRTR-1 plays a
central role in the maturation and function of the salivary glands and the kidney. CRTR-1 has also recently been identified as
a component of the complex transcriptional network that maintains pluripotency in embryonic stem (ES) cells. CRTR-1 was
previously shown to be a repressor of transcription. We examine the activity of CRTR-1 in ES and other cells and show that
CRTR-1 is generally an activator of transcription and that it modulates the activity of other family members, CP2, NF2d9 and
altNF2d9, in a cell specific manner. We also demonstrate that CRTR-1 activity is regulated by sumoylation at a single major
site, residue K30. These findings imply that functional redundancy with other family members may mask important roles for
CRTR-1 in other tissues, including the blastocyst stage embryo and embryonic stem cells.
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Introduction
The CP2 transcription factor family forms one branch of the
grainyhead-related protein family [1]. CP2 (also known as LSF
and LBP-1c in humans), its splice variant CP2d (also referred to as
LSF1d or LBP-1d in humans), NF2d9 (referred to as LBP-1a in
humans), its splice variant altNF2d9 (LBP-1b in humans) and
CRTR-1 (also known as Tcfcp2l1 and TFCP2L1 or LBP-9 in
humans) comprise this branch. CP2 and NF2d9 are widely, if not
ubiquitously, expressed. Both NF2d9 and its splice variant,
altNF2d9, generally act as transcriptional activators [2], and
CP2 can activate or repress transcription [1]. In contrast, CRTR-1
was reported to be a specific repressor of transcription [3], and its
expression is regulated both developmentally and tissue-specifical-
ly. Major sites of CRTR-1 expression include the early
mammalian blastocyst, embryonic stem (ES) cells and developing
and adult exocrine glands, particularly kidneys and salivary glands
[3,4,5,6]. Gene targeting of CRTR-1 in mice results in postnatal
lethality of up to 70% of mice, presumably due to renal failure
caused by defective duct maturation [4].
Mammalian CP2 family proteins are encoded by three separate
genes and all share high levels of amino acid sequence similarity
(83% or greater similarity between mouse CP2, NF2d9 and
CRTR-1). As such, it is predicted that members of the family will
recognise the same DNA motif (CNRG-N6-CNRG) [1] and bind
DNA as tetramers [7,8], forming either homomeric complexes or
heteromeric complexes with other family members, as has been
demonstrated for mouse CP2 and the human LBP-1a, b and c
proteins [2,7,8,9].
Several recent studies have implicated CRTR-1 (Tcfcp2l1) in
the complex transcription factor network responsible for the
maintenance of pluripotency in mouse ES cells. CRTR-1 has been
shown to bind to the regulatory regions of the Oct4 (Pou5f1), Nanog,
Sox2 and Klf4 genes [10], which are core components of this
network. The CRTR-1 gene itself appears to be regulated by
pluripotency factors, with demonstrated binding of Oct4, Nanog
and Jmjd1a, a histone demethylase required for pluripotency, to
upstream regions [11,12]. Despite a putative role in the expression
of genes required for pluripotency, the activity of CRTR-1 in ES
cells has not been tested to date.
We examine the activity of CRTR-1 in ES cells and also in the
kidney cell lines, COS-1 and HEK293T. We demonstrate that
CRTR-1 binds DNA and activates transcription through a CP2-
response element and show that it interacts with, and modulates
the activity of, other CP2 family proteins resulting in enhancement
or suppression of activity depending on the CP2 family member
and cell type. Moreover, we show that CRTR-1 can be
sumoylated and that this modification regulates its activity. These
findings demonstrate the potential for functional redundancy
between CRTR-1 and other family members and suggest that
activity should be considered in terms of the CP2 family profile in
a given cell, rather than that of an individual family member.
Results
CRTR-1 can act as a transcriptional activator
Many transcription factors have the ability to both activate and
repress transcription, as is seen for CP2 [1]. However, CRTR-1
and LBP-9 have been characterised as specific transcriptional
repressors [3,13,14]. To investigate the activity of CRTR-1 in ES
cells, a CP2-responsive luciferase reporter construct (pTK-4xWT-
CP2-LUC) was co-transfected with increasing amounts of a
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CRTR-1 expression plasmid (pEF-CRTR-1) into ES cells
(Figure 1A and Figure S1A). CRTR-1 was able to activate
transcription at all concentrations of CRTR-1 plasmid. Highest
activation levels, up to 5 fold, were obtained with lower amounts of
CRTR-1 plasmid. To determine if activation was cell type specific,
CRTR-1 activity was also examined in HEK293T and COS-1
cells. Up to 3 fold activation was observed in HEK293T cells, with
maximal activity when lower amounts of CRTR-1 plasmid were
used (Figure 1B). In COS-1 cells, CRTR-1 activity was lower
(Figure 1C). Although statistically reproducible, more than 2 fold
activation was rarely observed, suggesting cell type-specific
activity. (CRTR-1 expression levels in the three cell types are
shown in Figure S1B). In all cell types, CRTR-1 activity is
mediated through the CP2 binding elements in the reporter
construct, as mutation of these sites abrogates activity (data not
shown).
Mapping of activation/repression regions of CRTR-1
The repression domain of CRTR-1 had been mapped
previously to the extreme N-terminus (amino acids 1–52) [3]. In
contrast, the region that mediates repression in the human
homologue, LBP-9, has been shown to lie between residues 100
and 200 [13]. However, no activation was seen in these
experiments. In an attempt to identify residues responsible for
transcriptional activation in CRTR-1 and clarify the region
responsible for repression, a more comprehensive series of CRTR-
1 deletions fused to the GAL4 DNA binding domain were tested
for their ability to repress or activate a GAL4-responsive luciferase
reporter construct pTK-MH100x4-LUC (Figure 2). Western
blotting (Figure 2C) shows that all proteins were expressed,
although levels varied considerably between proteins. Maximal
repression (approximately 7 fold) was observed with full length
CRTR-1 and CRTR-1(48-479) (Figure 2B), although CRTR-
1(48–479) is expressed at lower levels (Figure 2C). The expression
levels of CRTR-1(198–479) and CRTR-1(48–479) are similar, but
only CRTR-1(48–479) represses. Together, these data suggest that
the region responsible encompasses residues 48–198. This is
supported by CRTR-1(1–200) which is expressed at levels similar
to that of CRTR-1(101–479) and represses well. Repression by
CRTR-1(48–200) is comparable to that of CRTR-1(1–200),
although it is expressed at lower levels. Despite being a well
characterised assay for mapping activation and repression motifs,
including those in other CP2 family members [2,13], we were
unable to detect any region of CRTR-1 with transactivation
properties using this method. (This is unlikely to be due to the
differences in protein levels as there was no consistent correlation
between activity and expression level in these experiments).
CRTR-1 interacts with CP2 family members and forms
heteromeric DNA binding complexes
CP2 family proteins interact with each other, forming
homomers and heteromers [9], with the functional DNA-binding
unit thought to be tetrameric [7,8]. To determine whether CRTR-
1 could interact with other CP2 family members, co-immunopre-
cipitations were performed (Figure 3) using FLAG-tagged CP2,
NF2d9 and altNF2d9 co-expressed with CRTR-1 in HEK293T
cells. CRTR-1 co-precipitated with all CP2 family proteins
(Figure 3A) and this interaction was confirmed with the reciprocal
co-immunoprecipitation (Figure 3B). Some background precipita-
tion of FLAG-CP2 and FLAG-NF2d9 was evident (see left-hand
panel of Figure 3B). Control experiments performed using pre-
immune serum or no antibody (data not shown) demonstrated that
this was due to non-specific binding of the FLAG-tagged protein to
the agarose beads. However, the greatly enriched pull-down of
FLAG-CP2 in the presence of ectopically expressed CRTR-1
indicates that the interaction between CRTR-1 and the other CP2
family members is genuine.
EMSA experiments demonstrated that CRTR-1-containing
complexes could specifically bind DNA containing a CP2-response
element (Figure 4A), as no competition for binding was observed
using an oligonucleotide containing a mutated CP2-response
element. The presence of CRTR-1 protein in the specific complex
was shown by super-shift using the CRTR-1 antibody. (Note: the
feint super-shifted bands seen with pre-immune serum do not
migrate at the same mobility as the super-shifted bands observed
with the CRTR-1 anti-serum). EMSA was also used to show that
heteromeric DNA-binding complexes are formed with CRTR-1
and CP2, NF2d9 or altNF2d9 as demonstrated by the interme-
Figure 1. CRTR-1 activates transcription in a cell type specific manner. ES (A), HEK293T (B), or COS-1 (C) cells were co-transfected with pTK-
4xWT-CP2-LUC and pEF-CRTR-1expression plasmid (CRTR-1) as indicated. Relative luciferase activity was determined by normalisation to renilla
activity. The data are presented relative to the activity of the reporter vector alone and are the mean 6 SEM of three independent experiments, each
of which was conducted in triplicate. Statistical significance was determined using a two-tailed unpaired t-test comparing the activities of different
amounts of CRTR-1 with vector alone. * denotes statistical significance with P,0.05, and *** denotes statistical significance with P,0.0001. Also see
supplementary data Figure S1.
doi:10.1371/journal.pone.0011702.g001
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diate mobility between that of CRTR-1 alone and the slower
migrating CP2, NF2d9 or altNF2d9 complexes (Figure 4B).
CRTR-1 modulates the activity of other CP2 family
members
To determine the effect of CRTR-1 on the transactivating
ability of CP2, NF2d9 and altNF2d9, reporter assays were
performed in ES, HEK293T and COS-1 cells (Figure 5; also see
Figure S2). Multiple cell lines were chosen to examine possible cell
specific effects. Co-transfection of CRTR-1 and CP2 resulted in
enhanced transactivation, with increases of up to 12 fold over that
of CP2 or CRTR-1 alone in ES cells (Figure 5A) and
approximately 3–7 fold in HEK293T cells (Figure 5B). This effect
was lost when higher amounts of CRTR-1 plasmid were used
(such as 150 ng and 200 ng; data not shown). More modest
increases in transactivation were observed when CRTR-1 and
NF2d9 were co-transfected (up to 3 fold and 5 fold in ES and
HEK293T cells respectively), and only when lower amounts of
CRTR-1 plasmid were used. In contrast, co-transfection of
CRTR-1 and altNF2d9 resulted in a reduction in luciferase levels
compared with altNF2d9 alone, indicating that CRTR-1 is able to
suppress altNF2d9-mediated activation (Figure 5A, B). In COS-1
cells, co-expression of CRTR-1 with CP2 or NF2d9 resulted in a
modest enhancement of activation, generally at lower amounts of
CRTR-1 (up to 2 fold over CP2 or NF2d9 alone; Figure 5C).
However, co-expression with altNF2d9 resulted in up to a 3.5 fold
increase in transactivation over that of altNF2d9 alone, not the
suppression of activity that was observed in ES and HEK293T
cells, demonstrating cell type-specific activity. These data show
that CRTR-1 is able to modulate the transcriptional activity
mediated by other CP2 family proteins, acting to enhance or
suppress transactivation depending on the family member and cell
type.
CRTR-1 is sumoylated at lysine 30
Cell specific behaviour of CRTR-1 is demonstrated by its lower
activity in COS-1 cells compared with ES and HEK293T cells and
by its ability to enhance, rather than suppress, altNF2d9 activity in
this cell type. While this may be due to a number of possible
factors, it is well documented that sumoylation of transcription
Figure 2. Mapping of CRTR-1 transactivation and repression domains. A. Schematic diagram of the CRTR-1 truncations fused to the GAL4
DNA-binding domain. Numbers in brackets represent the first and last amino acid of the CRTR-1 protein included in the protein. B. Luciferase reporter
assays of GAL4-CRTR-1 deletion constructs. HEK293T cells were co-transfected with 200 ng pTK-MH100x4-LUC and 200 ng of expression plasmid for
the GAL4-CRTR-1 deletion mutants together with 5 ng of pRL-SV40 for normalizing transfection efficiency. The data are presented relative to the
activity of the reporter construct alone and are the mean 6 SEM of three independent experiments, each of which was conducted in triplicate.
Statistical significance was determined using a two-tailed unpaired t-test comparing the activities of each GAL4-CRTR-1 deletion mutant with GAL4
vector alone. ** denotes statistical significance with P,0.01; *** denotes P,0.0001. C. Expression level of GAL4-CRTR-1 deletion mutants. Whole cell
lysates from HEK293T cells transfected with 2 mg of expression plasmid encoding GAL4-CRTR-1 deletion mutants were immunoblotted with an anti-
GAL4 antibody and detected by ECF (upper panel). The membrane was re-probed with rat anti-alpha-tubulin antibody and detected by enhanced
chemiluminescence (lower panel). The predicted sizes of the GAL4-CRTR-1 fusion proteins are as follows: GAL4-CRTR-1(1–47), 21 kD; GAL4-CRTR-
1(48–479), 64 kD; GAL4-CRTR-1(101–479), 58 kD; GAL4-CRTR-1(198–479), 47 kD; GAL4-CRTR-1(48–200), 33 kD; GAL4-CRTR-1(101–200), 27 kD; GAL4-
CRTR-1(1–100), 27 kD; GAL4-CRTR-1(1–200), 38 kD; GAL4-CRTR-1(1–479), 69 kD; and GAL4-CRTR-1(1–52), 22 kD. Specific bands corresponding to
GAL4-CRTR-1 deletion mutants are marked with an asterisk. Mass of molecular weight markers (kD) are shown.
doi:10.1371/journal.pone.0011702.g002
Figure 3. CRTR-1 co-immunoprecipitates with other CP2 family members. HEK293T cells were co-transfected with pEF-IRES-puro6
expression plasmids encoding CRTR-1 and FLAG-CP2, FLAG-NF2d9 or FLAG-altNF2d9, as indicated. Whole cell lysates were immunoprecipitated (IP)
with (A) anti-FLAG (M2) antibody or (B) anti-CRTR-1 antibody and immunoblotted (IB) with anti-CRTR-1 or anti-FLAG antibodies respectively. Western
blot analysis of input lysates is shown.
doi:10.1371/journal.pone.0011702.g003
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factors can affect their activity and it has also been reported that
erythroid-specific activity of CP2 proteins is mediated, in part, by
PIAS1, a sumo E3 ligase [2]. We, therefore, investigated the
possible role of sumoylation of CRTR-1 on its activity. To
determine whether CRTR-1 can be sumoylated, FLAG-SUMO-1
and CRTR-1 expression plasmids were co-transfected into COS-1
cells and whole cell lysates were immunoprecipitated with either
FLAG or CRTR-1 antibodies (Figure 6A). Unsumoylated CRTR-
1 runs as 2 doublets of approximately 54 and 60 kD. Immuno-
precipitated proteins of approximately 75–80 kD are detected with
both the CRTR-1 and FLAG antibodies, corresponding to
sumoylated forms of CRTR-1. Co-transfection with Ubc9, an
E2 sumo conjugating enzyme, or PIAS1 expression plasmids
enhanced the level of CRTR-1 sumoylation observed (Figure 6B).
Analysis of the CRTR-1 amino acid sequence identified 2
potential sites for sumoylation, FK30QE and LK464AE, conform-
ing to the consensus sequence, yKXE (where y is a hydrophobic
amino acid and X is any amino acid) [15]. Mutation of the lysine
residue in each motif to alanine demonstrated that lysine 30 (K30)
is the major site of sumoylation in CRTR-1, with no detectable
sumoylation of CRTR-1 when this residue is mutated (Figure 6C).
Sumoylation alters CRTR-1 activity
The CRTR-1 sumoylation mutants were tested for their
transactivation/suppression ability in reporter assays in ES and
COS-1 cells. All sumoylation mutants were expressed at levels
similar to that of wild-type CRTR-1 (see Figure S3). The activity
of the K30A mutant is up to 4 fold greater than that of wild type
CRTR-1in ES cells (Figure 7A), and similar activity is also
observed with the K2A mutant (data not shown). The K464A
mutant has comparable activity to wild type, consistent with K30
being the critical residue for sumoylation. Interestingly, unlike wild
type CRTR-1 which has limited activity in COS-1 cells, the K30A
mutant is able to activate the reporter construct to levels
approximately 9 fold greater than basal levels (Figure 7B),
suggesting that sumoylation of CRTR-1 in COS-1 cells abrogates
its ability to activate transcription. The effect of the K30A
mutation on the ability of CRTR-1 to modulate the activity of
other family members was tested in COS-1 cells (Figure 7C).
Interestingly, despite greater activity of K30A CRTR-1 alone,
overall activity when K30A CRTR-1 was co-transfected with CP2,
NF2d9 or altNF2d9 was not statistically significantly different from
that seen on co-transfection of CP2 family members with wild type
CRTR-1.
Discussion
The results presented here demonstrate that CRTR-1 is able to
act as a transcriptional activator or suppressor, depending on the
cell type and the complement of other CP2 family members
present. It is also likely that individual promoter context would
play a role in determining CRTR-1 activity, but this has not been
addressed here. We show for the first time that CRTR-1 is able to
activate transcription. This supports the indirect evidence that
LBP-9, the human homologue, may also both activate and repress
[13]. Using a GAL4-based assay we were unable to identify a
region of CRTR-1 responsible for mediating activation. A similar
result was seen for LBP-9 [13]. This could be due to a number of
factors including the possibility that fusion to the GAL4 DNA-
binding domain obscured identification of an activation domain at
the amino-terminus, or that CRTR-1 lacks a classical activation
domain and acts by altering the DNA-binding affinity or
conformation of partner proteins within the DNA-binding
heteromer to elicit activation or repression. The fact that
activation domains have been identified at the amino termini of
CP2, NF2d9 and altNF2d9 using similar methods [2] adds weight
to the possibility that CRTR-1 lacks an activation domain. Such a
model would imply that activation by CRTR-1 alone is mediated
by incorporation of endogenous CP2, NF2d9 or altNF2d9 into the
tetrameric complex, or by recruitment of activators to the
homomeric CRTR-1 complex. Further studies into the mecha-
nisms of activation and repression by CRTR-1 are required to
resolve this. Similarly, the observation that maximal activation
correlates with lower levels of ectopic CRTR-1 expression and
that activation decreases with increasing CRTR-1 levels, suggests
that the stoichiometry of the CRTR-1-containing complexes may
be an important mechanism for modulating CP2-family activity.
The GAL4-based studies mapped the region of CRTR-1 able to
mediate repression to between residues 48–200; these data are
consistent with the region identified in LBP-9 [13]. A previous
characterisation of CRTR-1 as a repressor, based on GAL4 assays
[3], mapped the region responsible for repression to residues 1–52
of CRTR-1 and saw no repression mediated by residues 47–479.
Unlike that study, we were unable to detect repression with the 1–
52 region and saw repression with the C-terminal portion of the
protein. Sequencing of the original constructs revealed a number
of mutations, although the 1–52 construct appeared to be correct.
The consistency of the data presented here with the analysis of
LBP-9 and a second study that uses the CRTR-1 1–52 construct
and detects only minor repression [2] supports the positioning of
the repression domain between residues 48–200.
The E3 sumo ligase PIAS1 has been shown previously to
interact with CP2 and affect its transcriptional activity [2].
However, this is the first direct demonstration that CP2 family
members can be sumoylated and that this modification appears to
affect activity of the protein. Immunoprecipitation experiments
showed that CRTR-1 can be sumoylated and that the major site of
SUMO-1 conjugation is K30. In addition to the predominant
SUMO-1-CRTR-1 bands of approximately 75–80 kD, several
higher molecular weight bands were also detected. These may
correspond to sumoylation at multiple sites, possibly K464 or
other non-consensus sites, as has been observed for Smad4 [16],
with conjugation at K30 required for efficient conjugation at
subsequent sites. A second possibility is that the higher bands
represent polysumoylated forms. Although SUMO-1 lacks a
consensus sumoylation sequence, polySUMO-1 chains have been
reported to form on RanBP2 [17]. Mutation of residue K30 of
CRTR-1 was sufficient to abolish detectable sumoylated CRTR-1
in COS-1 cells and resulted in increased activity in both ES and
COS-1 cells, suggesting that sumoylation at K30 blocks maximal
Figure 4. CRTR-1 binds the CP2 response element and forms DNA-binding complexes with other CP2 family members. A. Nuclear
extracts prepared from untransfected or pEF-CRTR-1 transfected HEK293T cells were incubated with FAM-labelled DNA probe containing a wild type
(WT) or mutated (Mut) CP2 response element. Binding reactions were performed in the presence or absence of anti-CRTR-1 antibody or pre-immune
serum (pre-immune) as indicated. Competitions were performed in the presence of 50-, 100-, or 200 fold excess unlabelled competitor oligo
containing the wild type or mutated CP2 response element. B. Nuclear extracts prepared from HEK293T over-expressing CRTR-1 and the indicated
CP2 family member were incubated with FAM-labelled DNA probe containing a wild type a-globin CP2 response element in the presence or absence
of anti-CRTR-1 antibody. Probe was in excess in all samples. Protein-DNA complexes were resolved by electrophoresis on a 4% native polyacrylamide
gel. SC, specific complex; SS, super-shifted complex; NS, non-specific complex.
doi:10.1371/journal.pone.0011702.g004
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Figure 5. Modulation of CP2, NF2d9 and altNF2d9 activity by CRTR-1. ES cells (A), HEK293T cells (B) and COS-1 cells (C) were co-transfected
with pTK-4xWT-CP2-LUC and the indicated amounts of expression plasmids encoding CRTR-1 and FLAG-tagged CP2, NF2d9 or altNF2d9. Relative
luciferase activity was determined by normalisation to renilla activity. Data are presented relative to the activity of the reporter construct alone and
are the mean 6 SEM of three independent experiments, each of which was conducted in triplicate. Also see supplementary Figure S2 for western
blots showing protein levels.
doi:10.1371/journal.pone.0011702.g005
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transactivation by CRTR-1. This is consistent with a repressive
role for sumoylation that is a common consequence of transcrip-
tion factor sumoylation [18]. The activity of CRTR-1 K30A in
COS-1 cells was significantly greater than that of wild type
CRTR-1, which had little activity in this cell type, suggesting that
this limited activity may be due to higher level sumoylation in
COS-1 cells compared to HEK293T or ES cells. Interestingly,
despite the higher activity of K30A CRTR-1, the overall level of
transcriptional activation observed when K30A was co-expressed
with other CP2 family members was generally similar to that seen
when other family members were co-expressed with wild type
CRTR-1 in both COS-1 and ES cells. One possible explanation
for this may be that high level expression of the other CP2 proteins
in our assays may saturate machinery required for transcriptional
activation of the reporter gene to a maximal level. Alternatively,
CRTR-1 sumoylation may interfere with heteromer formation
and activity. This effect can be observed when CRTR-1 alone is
transfected (compare the activity of CRTR-1 and CRTR-1 K30A;
Figure 7A,B), but is undetectable when other family members are
co-transfected due to the high level expression of the other family
members driving the equilibrium of complex formation to the
heteromeric state. The effect on CRTR-1 activity could be
mediated by a decrease in DNA binding on sumoylation, as has
been reported for Sox2 and Heat Shock Factors [19,20], by
recruitment of co-repressors [18], or by altering subcellular
localisation such that CRTR-1 is sequestered and unavailable,
such as occurs with Sp3 and ELK-1 [21,22].
The amino terminal sumoylation sequence of CRTR-1, FKQE,
is conserved in mouse CP2, NF2d9 and altNF2d9 proteins,
suggesting that these family members may also be sumoylated.
However, CRTR-1 has a putative phosphorylation-dependent
sumoylation motif (PDSM) [23] adjacent to the K30 residue which
is absent in the other proteins (and is also absent from the putative
CRTR-1 K464 sumoylation motif). Whether the presence or
absence of this motif influences sumoylation of CRTR-1 may
provide insight into both the role of sumoylation and its regulation
of this family of proteins.
The key findings of this work are that CRTR-1 is able to
activate transcription, contrary to previous reports, form DNA-
binding heteromers with other CP2 family members and
modulate their activity. This implies that these transcription
factors should be studied as a family, depending on the
complement of family members expressed in a given cell type
or tissue of interest. In the case of CRTR-1, gene targeting has
identified an important role for this protein in the kidney [4,5],
but it also suggested that expression of CRTR-1 is not critical in
the inner cell mass of the blastocyst and ES cells. However, CP2,
NF2d9 and altNF2d9 are also expressed in ES cells [2]. The
recent findings that CRTR-1 binds to key pluripotency factor
regulatory regions [10] suggests that CP2 family complexes
should be examined to determine the function of this family in
pluripotent cells.
Materials and Methods
Plasmid constructs
PCR amplification from mouse kidney cDNA or D3 ES cell
cDNA was used to generate fragments encoding the full-length
open reading frame of CRTR-1, CP2, NF2d9 and altNF2d9. Note
the CRTR-1 sequence corresponds to GenBank Accession
number NM_023755. FLAG tags were incorporated on the 59
end where indicated. XhoI and NotI restriction sites were
incorporated on the 59 and 39 ends respectively and used to clone
the fragments into XhoI/NotI-digested pEF-IRES-puro6 vector
[24] to generate pEF-CRTR-1, pEF-FLAG-NF2d9 and pEF-
FLAG-altNF2d9. The CP2 expression vector, pEF-FLAG-CP2,
was generated via incorporation of an EcoRI site in the forward
primer and NotI site in the reverse primer and subsequent cloning
into EcoRI/NotI-digested pEF-IRES-puro6 vector. The pEF-
FLAG-SUMO-1 plasmid was generated by PCR amplification of
the FLAG-SUMO-1 open reading frame from pCMV-FLAG-
SUMO-1 [25] with incorporation of XhoI and NotI sites as above
for cloning into pEF-IRES-puro6. CRTR-1 sumoylation site
mutations K30A and K464A and the double mutation K30A/
K464A (2KA) were generated in pEF-CRTR-1 using Quik-
Change Site-Directed Mutagenesis (Stratagene) and the following
primer pairs: K30A 59-GCT CTG CCT ATC TTC GCA CAG
GAA GAG CCG CAG C-39 and 59-GCT GCG GCT CTT CCT
GTG CGA AGA TAG GCA GAG C-39; K464A59-CCT CAG
CAC ATT AGC AGC AGA AAG CAA TGA TGG C-39 and 59-
GCC ATC ATT GCT TTC TGC TGC TAA TGT GCT GAG
G-39. The GAL4-CRTR-1 deletions are in-frame fusions between
the yeast GAL4 DNA-binding domain (amino acids 1-147) and
fragments of CRTR-1. These constructs were generated in the
pGALO plasmid [26] after PCR amplification of the full-length
open reading frame or various regions of CRTR-1 as specified. All
PCR primers were designed to incorporate SacI and SalI
restriction enzyme sites at the 59 and 39 ends respectively,
permitting cloning into SacI/SalI-digested pGALO vector. The
following oligonucleotides were used to generate the constructs
specified: pGAL4-CRTR-1 59-ATA GTC GAC CAG CCA TGC
TGT TCT GGC-39 and 59-AGA GCT CAC TCA TTC TGC
TTA AAC GTG TC-39; pGAL4-CRTR-1(1–47) 59-ATA GTC
GAC CAG CCA TGC TGT TCT GGC-39 and 59-AGA GCT
CAT AGG GGC GGC AAG CGG GC-39; pGAL4-CRTR-1(48-
479)59-CGC GTC GAC AGT ATG TGT TGT GTG CCG C-39
and 59-AGA GCT CAG AGT CCA CAC TTC AGG ATG-39;
pGAL4-CRTR-1(1–100) 59-ATA GTC GAC CAG CCA TGC
TGT TCT GGC-39 and 59-AGA GCT CAG ATG ATG CTC
TTC ACA TAT TTC G-39; pGAL4-CRTR-1(1-200) 59-ATA
GTC GAC CAG CCA TGC TGT TCT GGC-39 and 59-AGA
GCT CAC TCA TTC TGC TTA AAC GTG TC-39; pGAL4-
CRTR-1(101–479) 59-ATC GTC GAC GTG TCG TTT TCC
ATG ACC G-39 and 59-AGA GCT CAG AGT CCA CAC TTC
AGG ATG-39; pGAL4-CRTR-1(198–479) 59-CGC GTC GAC
Figure 6. CRTR-1 is sumolyated at K30 and sumoylation is enhanced by PIAS1 or Ubc9. A. COS-1 cells were co-transfected with pEF-CRTR-
1and pEF-FLAG-SUMO-1 expression plasmids as indicated. Whole cell lysates were immunoprecipitated (IP) with anti-FLAG or anti-CRTR-1 antibody
and analysed by immunoblotting (IB) as indicated to detect sumoylated proteins. Bracket identifies higher molecular weight bands as possible
multiple or polysumoylated CRTR-1. B. COS-1 cells were co-transfected with pEF-CRTR-1, pEF-FLAG-SUMO-1, pEF-FLAG-Ubc9, and pEF-FLAG-PIAS1
expression plasmids as indicated. Whole cell lysates were immunoprecipitated with anti-FLAG or anti-CRTR-1 antibody and analysed by
immunoblotting with anti-CRTR-1 or anti-FLAG antibody respectively to detect sumoylated proteins (bracket). Immunoblotting of input lysates with
anti-CRTR-1 antibody detected both sumoylated and unsumoylated CRTR-1. C. COS-1 cells were co-transfected with pEF-CRTR-1, pEF-K30A, pEF-
K464A or pEF-2KA together with pEF-FLAG-SUMO-1 expression plasmids. Whole cell lysates were immunoprecipitated with anti-CRTR-1 antibody and
analysed by immunoblotting with anti-FLAG antibody respectively to detect sumoylated proteins (bracket). Immunoblotting of input cell lysates with
anti-CRTR-1 antibody detected unsumoylated CRTR-1. Molecular weight markers are shown (kD). Also see Figure S3A which is a re-probing of the blot
in (C) with anti-CRTR-1 antibody.
doi:10.1371/journal.pone.0011702.g006
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Figure 7. The effect of K30 mutation on CRTR-1 activity. ES cells (A) and COS-1 cells (B) were co-transfected with the indicated amounts of
pEF-CRTR-1, pEF-K30A, pEF-K464A or pEF-2KA expression plasmids together with pTK-4xWT-CP2-LUC reporter construct. Relative luciferase activity
was determined by normalisation to renilla activity. The data presented are representative experiments of three independent experiments, each of
which was conducted in triplicate. Error bars represent the SEM of the triplicate samples. C. The effect of the K30A mutant on the activity of CP2,
NF2d9 and altNF2d9 was examined in COS-1cells. Cells were co-transfected with the indicated amounts of pEF-K30A, pEF-K464A or pEF-CRTR-1,
expression plasmids for CP2, NF2d9 or altNF2d9 and pTK-4xWT-CP2-LUC reporter construct. Firefly luciferase activity was normalised to renilla
activity. The data are presented relative to the activity of the reporter vector alone and are the combined data from three independent experiments
(6SEM), each performed in triplicate. Shading has been used to aid comparison between the effects of wild type and K30A CRTR-1.
doi:10.1371/journal.pone.0011702.g007
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AGA ATG AGA GTG GGG ACT AC-39 and 59-AGA GCT
CAG AGT CCA CAC TTC AGG ATG-39; pGAL4-CRTR-
1(101–200) 59-ATC GTC GAC GTG TCG TTT TCC ATG
ACC G-39 and 59-AGA GCT CAC TCA TTC TGC TTA AAC
GTG TC-39; pGAL4-CRTR-1(48–200) 59-CGC GTC GAC
AGT ATG TGT TGT GTG CCG C-39 and 59-AGA GCT
CAC TCA TTC TGC TTA AAC GTG TC-39. These constructs
were assayed for activity using the GAL4-responsive luciferase
reporter construct pTK-MH100x4-LUC [26]. The CP2-respon-
sive luciferase reporter construct pTK-4xWT-CP2-Luc was
generated by HindIII/BamHI digestion of pTK-MH100x4-LUC
to remove the GAL4-responsive element which was subsequently
replaced with 2 sets of double stranded oligonucleotides (59-ATA
GTC GAC CAG CCA TGG CCT GGG CTC TGA AG-39/59-
ATA AAG CTT GAG CTC CTA CTT GAG AAT GAC ATG-
39 and 59-ATA GTC GAC CAG CCA TGG ATA GAG AGA
AAA TGG AG-39/59-ATA AAG CTT GAG CTC ACA AAC
TTG ACT CTT CTT G-39) constituting 4 copies of the a-globin
CP2 response element [27]. PIAS1 and Ubc9 full-length open
reading frames, originally PCR amplified from mouse kidney
cDNA, were FLAG-tagged at the amino terminus and cloned into
pEF-IRES.puro6 to generate pEF-FLAG-Ubc9 and pEF-FLAG-
PIAS1. pXMT2 [28], pXMT2.PIAS1 and pXMT2.Ubc9 were
gifts from Steven Rodda (University of Adelaide).
Antibodies
CRTR-1-specific rabbit polyclonal antiserum was generated
using a 21 amino acid peptide of the CRTR-1 amino-terminus
(MLFWHTQPEHYNQHNSGSYLR) conjugated to the carrier
diphtheria toxoid (Mimotopes). This sequence is common to
CRTR-1 and LBP-9, but is not present in other CP2 family
members. Affinity purification of the antibody was performed
using the inoculating peptide. Mouse FLAG M2 antibody was
obtained from Sigma and used at a dilution of 1:500. Anti-
GAL4(DBD) rabbit polyclonal antibody sc-577 was purchased
from Santa Cruz and used at 1:500. Anti-rat alpha-tubulin
(MCA78G) was purchased from Serotec and used at a dilution of
1:2000. Anti-mouse and anti-rabbit alkaline phosphatase second-
ary antibodies (used at 1:2000 dilution) were obtained from
Rockland. HRP-conjugated anti-rat secondary antibody (P0450)
was purchased from Dako and used at a dilution of 1:10000.
Cell culture and luciferase assays
COS-1 and HEK293T cells (CRL-1650 and CRL-11268;
ATCC, Manassas, USA) were routinely maintained in DMEM
(Invitrogen) supplemented with 10% FCS. D3 ES cells [29] were
maintained in DMEM supplemented with 1000 U/ml leukaemia
inhibitory factor, 0.1 mM 2-mercaptoethanol and 10% FCS.
COS-1, HEK293T and ES cells were seeded at 3.56104, 56104
or 3.56104 cells/well of 24-well trays (Falcon) respectively. COS-1
and HEK293T cells were transfected 16-24 h after seeding and
ES cells were transfected 1 h after seeding. Triplicate wells were
transfected with 200 ng/well pTK-4xWT-CP2-Luc or pTK-
MH100x4-LUC reporter plasmid and 5 ng/well pRL-SV40
renilla plasmid using FuGene 6 (Roche), according to the
manufacturer’s instructions. The total amount of DNA transfected
was standardised to 605 ng with the appropriate empty vector.
Cell extracts were assayed 40 h post-transfection using the Dual-
Luciferase reporter assay system (Promega) according to the
manufacturer’s instructions. Relative luciferase activity was
determined as a ratio of Firefly/Renilla luciferase levels and data
were expressed as the mean (6 SEM) of triplicate values obtained
from a representative experiment that was independently repeated
at least 3 times, unless otherwise stated. When data from multiple
experiments were combined, statistical analysis was performed
using the two-tailed unpaired t-test. A value of P,0.05 was
considered statistically significant.
Coimmunoprecipitation, sumoylation and western blot
analyses
For co-immunoprecipitation studies, HEK293T or COS-1 cells
were plated at a density of 16106 or 2.56105 cells per 6 cm dish
respectively. Cells were transfected with equal amounts (1 mg) of
plasmid encoding CRTR-1 and CP2 family members. The total
amount of DNA transfected was made up to 2 mg with pEF-IRES-
puro6. Cells were lysed 40 h post-transfection in 1 ml IP lysis
buffer [50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% (v/v)
glycerol, 1% Triton X-100, 10 mM EDTA, 1 X protease inhibitor
cocktail (Roche)]. Lysates were incubated with 10 mg anti-CRTR-
1 affinity purified antibody or 20 mg anti-FLAG M2 antibody
(Sigma) for 3 h at 4uC and immunoprecipitated by incubation
with 50 ml protein-A agarose beads (Roche). Immunoprecipitated
proteins were eluted from the beads by boiling in 25 ml 2X SDS
load buffer [125 mM Tris-HCl pH 6.8, 4% (v/v) SDS, 20% (v/v)
glycerol, 0.1% (w/v) bromophenol blue, 5% (v/v) 2-mercaptoeth-
anol] for 5 min, resolved by SDS-PAGE and subjected to western
blot analysis. For detection of sumoylated proteins, COS-1 cells
were plated at 56105 cells per 10 cm dish and transfected with
plasmids encoding CRTR-1 (3 mg) and FLAG-SUMO-1 (3 mg).
The total amount of DNA transfected was made up to 6 mg with
pEF-IRES-puro6. Cells were lysed in 1 ml IP lysis buffer [50 mM
Tris-HCl pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 1% Triton
X-100, 10 mM EDTA) containing 1x protease inhibitor cocktail
(Roche), 10 mM Iodoacetamide (Sigma), and 10 mM N-ethylma-
leimide (NEM; Sigma)]. FLAG-SUMO-1 conjugated proteins
were immunoprecipitated using 20 ml anti-FLAG M2 affinity gel
according to the manufacturer’s protocol (Sigma). CRTR-1
proteins were immunoprecipitated as described above and
analysed by western blotting.
Electrophoretic mobility shift assays
HEK293T cells (1.56106 cells/10 cm dish) and COS-1 cells
(56105/10 cm dish) were transfected with plasmids encoding
CRTR-1 (3 mg) and CP2 family members (3 mg). Total DNA
transfected was made up to 6 mg with pEF-IRES-puro6. Cells
were lysed 40 h post-transfection with 2.5 pellet volumes of lysis
buffer A [10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl,
0.4% Igepal (Sigma), 10% Ficoll-400, 1 mM PMSF, 1x protease
inhibitor cocktail (Roche), 1 mM DTT]. Following removal of the
cytosolic fraction, the nuclear fraction was lysed in 1.5 pellet
volumes of lysis buffer B [20 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 0.5 mM EDTA, 20% glycerol, 0.42 M KCl, 1 mM
PMSF, 1 mM DTT, 1x protease inhibitor cocktail]. Protein-DNA
binding reactions contained 7–10 mg nuclear protein extract, 1x
gel-shift binding buffer [10 mM Tris-HCl pH 8.0, 10% glycerol,
2% PVA, 0.1 mM EDTA, 100 mM KCl and 1 mM DTT], 1 mg
Poly(dI-dC) and 20 nM carboxyfluorescein (FAM)-labelled an-
nealed oligonucleotides in a total volume of 20 ml. Reactions were
incubated at room temperature for 30 min prior to electrophoresis
on a 0.5x TBE buffered 4% PAGE gel that had been pre-
electrophoresed for 2 h. Electrophoresis was performed at at a
constant voltage of 200V for 2.5 h and results were detected using
a Typhoon Trio Variable Mode Imager (Amersham Biosciences).
For supershift analysis, 4 mg anti-CRTR-1 affinity purified
antibody or pre-immune serum was incubated with 7-10 mg
nuclear protein extract for 15 min on ice prior to addition of the
DNA probe. Sequence of the double-stranded wild type mouse a-
globin CP2-binding site oligonucleotide is 59-TCG AGC AAG
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CAC AAA CCA GCC AAC-39 and that of the mutant CP2-
binding site is 59-TCG AGA AAT CAC AAA ACA TCC AAC-39
[27].
Supporting Information
Figure S1 A. CRTR-1 activates transcription in ES cells. Cells
were co-transfected with pTK-4xWT-CP2-LUC and pEF-CRTR-
1 expression plasmid (CRTR-1) as indicated. Relative luciferase
activity was determined by normalisation to renilla activity. The
data are presented relative to the activity of the reporter vector
alone and are the mean 6SEM of two independent experiments,
each of which was conducted in triplicate. Note: fold activation
seen here is higher than that seen in the comparable experiments
in Figure 1. Our evidence suggests that this difference is likely to
be due to a change in DNA preparation method between the
experiments. Endotoxin-free DNA was used for all transfections,
apart from those in S1A. B. Western blot analysis of ES,
HEK293T and COS-1 cells transfected with pTK-4xWT-CP2-
LUC and pEF-CRTR-1 expression plasmid (CRTR-1) as
indicated. Cells were lysed 48 h post-transfection and 20% of
total cell lysate was analysed. The upper panel shows membrane
probed with rabbit anti-LBP-9 antibody (LS-C30155, LifeSpan
Biosciences, 1:500) and detected using enhanced chemifluores-
cence. The lower panel is a re-probing of the membrane with rat
anti-alpha-tubulin antibody and detection using chemilumines-
cence.
Found at: doi:10.1371/journal.pone.0011702.s001 (0.38 MB TIF)
Figure S2 Western blot analysis of CRTR-1, FLAG-CP2,
FLAG-NF2d9 and FLAG-altNF2d9 expression levels. Western
blot analyses were performed on 30% of the HEK293T cell lysate
from experiments included in Fig. 5B. Cells were transfected with
the appropriate expression plasmids, as indicated (ng). Proteins
were detected using ECF and anti-CRTR-1 or anti-FLAG (M2)
antibodies.
Found at: doi:10.1371/journal.pone.0011702.s002 (1.41 MB TIF)
Figure S3 A. This is a re-probing of the blot from Fig. 6C with
anti-CRTR-1 antibody to demonstrate that CRTR-1 is success-
fully immunoprecipitated and that levels of wild-type and
sumoylation-mutant CRTR-1 proteins are expressed at compara-
ble levels. B. Western blot analysis of ES cells transfected with the
indicated amounts of pEF-CRTR1, pEF-K30A, pEF-K2A or
pEF-K464A and pTK-4xWT-CP2-LUC reporter construct (ng).
Cells were lysed 48 h post-transfection and 20% of total cell lysate
was analysed. The upper panel shows membrane probed with
rabbit anti-LBP-9 antibody (LS-C30155, LifeSpan Biosciences,
1:500) to detect CRTR-1 (arrow) using enhanced chemifluores-
cence. The lower panel is re-probing of the membrane with rat
anti-alpha-tubulin antibody and detection using chemilumines-
cence.
Found at: doi:10.1371/journal.pone.0011702.s003 (0.33 MB TIF)
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